Two weeks after Teva touted promising long-term data for its Sanofi-partnered bowel disease drug, the Israeli pharma ...
In an effort to accelerate timelines and decrease development costs of life-saving vaccines, the Infectious Disease Research Institute (IDRI) and Sanofi Pasteur today announce the establishment of the ...
Once upon a time, Sanofi Pasteur in Swiftwater, Monroe County, was the principal vaccine brand of Sanofi, the Paris-based international pharmaceutical company. However, in 2022 Sanofi underwent a ...
While the flu vaccine is the best way to prepare for flu season, older adults don't have as robust an immune response to the jab as young people do. To address this problem, Sanofi Pasteur formulated ...
Drugmaker Sanofi-Aventis employs 100,000 people worldwide, but it is the 66 employees at its Oro Valley research center who have developed about half of the company's drug compounds. The ...
Analyst Graham Parry of Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), retaining the price target of €122.00. Graham Parry has given his Buy rating due to a ...
Drugmaker Sanofi Pasteur said Tuesday it is launching an effort to research and develop a vaccine to prevent the Zika virus, after the World Health Organization declared a global emergency over its ...
We have seen $58,972,462 of award payments to $SNY over the last year. Here are some of the awards which we have have seen pay out the most over the last year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results